Amarantus Bioscience Holdings, Inc.
(Other OTC/NBB : AMBS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading AMBS News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.82%69.941.0%$908.23m
AMGNAmgen Inc.
0.32%174.560.8%$649.28m
BIIBBiogen Inc.
0.13%285.130.9%$505.04m
CELGCelgene Corporation
-1.03%118.231.0%$479.40m
REGNRegeneron Pharmaceuticals, Inc.
0.01%361.011.9%$333.88m
ALXNAlexion Pharmaceuticals, Inc.
0.84%131.542.0%$300.31m
INCYIncyte Corporation
7.59%131.212.3%$226.98m
TSROTESARO, Inc.
0.52%186.9015.3%$192.36m
ILMNIllumina, Inc.
-0.63%160.003.9%$139.16m
VRTXVertex Pharmaceuticals Incorporated
0.40%86.072.6%$132.86m
CLVSClovis Oncology, Inc.
0.33%57.9016.4%$126.32m
EXELExelixis, Inc.
-0.23%21.695.5%$125.29m
AAgilent Technologies, Inc.
0.47%51.711.7%$109.32m
BMRNBioMarin Pharmaceutical Inc.
-1.99%87.514.0%$94.94m
ACADACADIA Pharmaceuticals Inc.
-1.72%38.8819.0%$94.62m

Company Profile

Amarantus BioScience Holdings, Inc. is a publicly traded biotechnology company focused on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in San Francisco, CA.